OTREXUP 25 MG/0.4 ML AUTO-INJ

methotrexate
$475.8070per ML
High Outlier

Strength

25 mg/.4mL

NDC

54436002504

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

8/20/2025

Active Ingredients

METHOTREXATE

Approval Type

New Drug (NDA)

FDA Application

NDA204824

On Market Since

10/11/2013

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.9%

3Y

+21.6%

5Y

+21.6%

All

+21.6%

Generic Alternatives

Save up to 39%

1 alternative • Same active ingredient